Dorsey & Whitney Trust CO LLC Acquires Shares of 1,520 iShares Biotechnology ETF (NASDAQ:IBB)

Dorsey & Whitney Trust CO LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBBFree Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 1,520 shares of the financial services provider’s stock, valued at approximately $206,000.

Several other large investors have also recently modified their holdings of IBB. Crewe Advisors LLC lifted its stake in iShares Biotechnology ETF by 42.9% in the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock worth $35,000 after purchasing an additional 78 shares during the last quarter. Northwest Financial Advisors bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $42,000. Values First Advisors Inc. purchased a new position in iShares Biotechnology ETF during the 4th quarter valued at $43,000. Tennessee Valley Asset Management Partners bought a new position in iShares Biotechnology ETF in the 4th quarter valued at $44,000. Finally, Massmutual Trust Co. FSB ADV grew its position in iShares Biotechnology ETF by 164.2% in the 4th quarter. Massmutual Trust Co. FSB ADV now owns 362 shares of the financial services provider’s stock valued at $49,000 after acquiring an additional 225 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.2 %

NASDAQ:IBB opened at $135.50 on Tuesday. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $141.16. The stock has a fifty day simple moving average of $132.50 and a 200-day simple moving average of $132.86.

iShares Biotechnology ETF Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were issued a dividend of $0.126 per share. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a yield of 0.37%.

iShares Biotechnology ETF Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

See Also

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBBFree Report).

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.